| 1 |
Bellomo R, Kellum JA, Ronco C. Acute kidney injury [J]. Lancet,2012, 380(9843): 756-766.
|
| 2 |
Lameire NH, Bagga A, Cruz D, et al. Acute kidney injury: an increasing global concern [J]. Lancet, 2013, 382(9887): 170-179.
|
| 3 |
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guidelines for Acute Kidney Injury [J]. Kidney Int, 2012, 2(1 Suppl): 1-138.
|
| 4 |
Li PK, Burdmann EA, Mehta RL. Acute kidney injury: global health alert [J]. Kidney Int, 2013, 83(3): 372-376.
|
| 5 |
Palevsky PM, Zhang JH, O’Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury [J]. N Engl J Med, 2008, 359(1): 7-20.
|
| 6 |
Bellomo R, Cass A, Cole L, et al. Intensity of continuous renalreplacement therapy in critically ill patients [J]. N Engl J Med,2009, 361(17): 1627-1638.
|
| 7 |
Wald R, Quinn RR, Luo J, et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis [J].JAMA, 2009, 302(11): 1179-1185.
|
| 8 |
Macedo E, Zanetta DM, Abdulkader RC. Long-term follow-up of patients after acute kidney injury: patterns of renal functional recovery [J]. PLos One, 2012, 7(5): e36388.
|
| 9 |
Friedenstein AJ, Chailakhyan RK, Latsinik NV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo[J]. Transplantation, 1974, 17(4): 331-340.
|
| 10 |
Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues [J]. Transplantation, 1968, 6(2): 230-247.
|
| 11 |
Uccelli A, Moretta L, Pistoia V. Immunoregulatory function of mesenchymal stem cells [J]. Eur J Immunol, 2006, 36(10): 2566-2573.
|
| 12 |
Le Blanc K, Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience [J]. J Intern Med, 2007, 262(5):509-525.
|
| 13 |
Morigi M, Imberti B, Zoja C, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure [J]. J Am Soc Nephrol, 2004, 15(7): 1794-1804.
|
| 14 |
Herrera MB, Bussolati B, Bruno S, et al. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury [J].Int J Mol Med, 2004, 14(6): 1035-1041.
|
| 15 |
Togel F, Weiss K, Yang Y, et al. paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury [J]. Am J Physiol Renal Physiol, 2007, 292(5):F1626-1635.
|
| 16 |
Qian H, Yang H, Xu W, et al. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells [J]. Int J Mol Med, 2008, 22(3): 325-332.
|
| 17 |
Yokoo T, Ohashi T, Shen JS, et al. Humanmesenchymal stem cells in rodent whole- embryo culture are reprogrammed to contribute to kidney tissues [J]. Proc Natl Acad Sci USA, 2005, 102(9):3296-3300.
|
| 18 |
Herrera MB, Bussolati B, Bruno S, et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury[J]. Kidney Int, 2007, 72(4): 430-441.
|
| 19 |
Duffield JS, Park KM, Hsiao LL, et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells [J]. J Clin Invest, 2005, 115(7): 1743-1755.
|
| 20 |
Vogetseder A, Karadeniz A, Kaissling B, et al. Tubular cell proliferation in the healthy rat kidney [J]. Histochem Cell Biol,2005, 124(2): 97-104.
|
| 21 |
Vogetseder A, Palan T, Bacic D, et al. Proximal tubular epithelial cells are generated by division of differentiated cells in the healthy kidney [J]. Am J Physiol Cell Physiol, 2007, 292(2): C807-813.
|
| 22 |
Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrowderived cells, are the major source for regeneration in postischemic kidney [J]. J Clin Invest, 2005, 115(7): 1756-1764.
|
| 23 |
Morigi M, Introna M, Imberti B, et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice [J]. Stem Cells, 2008, 26(8): 2075-2082.
|
| 24 |
Eliopoulos N, Zhao J, Bouchentouf M, et al. Human marrowderived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice postintraperitoneal injection [J]. Am J Physiol Renal Physiol, 2010,299(6): F1288-1298.
|
| 25 |
Bi B, Schmitt R, Israilova M, et al. Stromal cells protect against acute tubular injury via an endocrine effect [J]. J Am Soc Nephrol,2007, 18(9): 2486-2496.
|
| 26 |
Togel F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms [J]. Am J Physiol Renal Physiol, 2005, 289(1): F31-F42.
|
| 27 |
Imberti B, Morigi M, Tomasoni S, et al. Insulin-like growth factor-1 sustains stem cell-mediated renal repair [J]. J Am Soc Nephrol, 2007, 18(11): 2921-2928.
|
| 28 |
Hagiwara M, Shen B, Chao L, et al. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation [J]. Hum Gene Ther, 2008, 19(8): 807-819.
|
| 29 |
Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymalstem cells on rat acute kidney injury [J]. Stem Cells Dev, 2011, 20(1): 103-113.
|
| 30 |
Yuan L, Wu MJ, Sun HY, et al. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury [J]. Am J Physiol Renal Physiol, 2011, 300(1): F207-F218.
|
| 31 |
Ghannam S, Pène J, Torcy-Moquet G, et al. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype [J]. J Immunol, 2010,185(1): 302-312.
|
| 32 |
Morigi M, Benigni A. Mesenchymal stem cells and kidney repair[J]. Nephrol Dial Transplant, 2013, 28(4): 788-793.
|
| 33 |
Hu J, Zhang L, Wang N, et al. Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions [J]. Kidney Int, 2013, 84(3): 521-531.
|
| 34 |
Nemeth K, Leelahavanichkul A, Yuen PST, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E-2-dependent reprogramming of host macrophages to increase their interleukin-10 production [J]. Nat Med, 2009, 15(1): 42-49.
|
| 35 |
Kim J, Hematti P. Mesenchymal stem cell-educated macrophages:A novel type of alternatively activated macrophages [J].ExpHematol, 2009, 37(12): 1445-1453.
|
| 36 |
Chen L, Tredget EE, Wu PY, et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing [J]. PLos one, 2008,3(4): e1886.
|
| 37 |
Maggini J, Mir kin G, Bognanni I, et al. Mouse bone marrowderived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile [J]. PLos one, 2010, 5(2): e9252.
|
| 38 |
Zhang QZ, Su WR, Shi SH, et al. Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing [J]. Stem Cells, 2010,28(10): 1856-1868.
|
| 39 |
Wynn RF, Hart CA, Corradi-Perini C, et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow[J]. Blood, 2004, 104(9): 2643-2645.
|
| 40 |
Lange C, Togel F, Ittrich H, et al. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats [J]. Kidney Int, 2005, 68(4): 1613-1617.
|
| 41 |
Togel F, Isaac J, Hu ZM, et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury [J]. Kidney Int, 2005, 67(5): 1772-1784.
|
| 42 |
Honczarenko M, Le Y, Swierkowski M, et al. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors [J]. Stem Cells, 2006, 24(4):1030-1041.
|
| 43 |
Ponte AL, Marais E, Gallay N, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells:Comparison of chemokine and growth factor chemotactic activities [J]. Stem Cells, 2007, 25(7): 1737-1745.
|
| 44 |
Liu N, Patzak A, Zhang J. CXCR4-overexpressing bone marrowderived mesenchymal stem cells improve repair of acute kidney injury [J]. Am J Physiol Renal Physiol, 2013, 305(7):F1064-F1073.
|
| 45 |
Yu X, Lu C, Liu H, et al. Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury [J]. PLos one, 2013, 8(5): e62703.
|
| 46 |
Liu N, Tian J, Cheng J, Zhang J. Effect of erythropoietin on the migration of bone marrow-derived mesenchymal stem cells to the acute kidney injury microenvironment [J]. Exp Cell Res, 2013,319(13): 2019-2027.
|
| 47 |
Gheisari Y, Azadmanesh K, Ahmadbeigi N, et al. Genetic modification of mesenchymal stem cells to over-express CXCR4 and CXCR7 does not improve the homing and therapeutic potentials of these cells in experimental acute kidney injury [J].Stem Cells Dev, 2012, 21(16): 2969-2980.
|
| 48 |
Ponte AL, Marais E, Gallay N, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells:comparison of chemokine and growth factor chemotactic activities [J]. Stem Cells, 2007, 25(7): 1737-1745.
|
| 49 |
Zhu H, Mitsuhashi N, Klein A, et al. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix [J]. Stem Cells, 2006, 24(4): 928-935.
|
| 50 |
Karp JM, Leng-Teo GS. Mesenchymal stem cell homing the devil is in the details [J].Cell stem cell, 2009, 4(3): 206-216.
|
| 51 |
Cheng K, Rai P, Plagov A, et al. Transplantation of bone marrowderived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms [J]. Exp Mol Pathol, 2013, 94(3): 466-473.
|
| 52 |
Drexler H, Meyer GP, Wollert KC. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial [J]. Nat Clin Pract Cardiovasc Med, 2006, 3(Suppl 1):S65-S68.
|
| 53 |
Gooch A, Doty J, Flores J, et al. Initial report on a phase I clinical trial: prevention and treatment of post-operative acute kidney injury with allogeneic mesenchymal stem cell in patients who require on-pump cardiac surgery [J]. Cell Ther Transplant, 2008,1(2): 31-35.
|
| 54 |
http: //www. som. tulane. edu/gene therapy/distribute. shtml
|
| 55 |
Kunter U, Rong S, Boor P, et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes [J]. J Am Soc Nephrol, 2007, 18(6): 1754-1764.
|
| 56 |
Breitbach M, Bostani T, RoellW, et al. Potential risks of bone marrow cell transplantation into infarcted hearts [J]. Blood, 2007,110(4): 1362-1369.
|
| 57 |
Tögel F, Yang Y, Zhang P, et al. Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury [J]. Am J Physiol Renal Physiol,2008, 295(1): F315-F321.
|